Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort

[1]  C. Roberts,et al.  Gastrointestinal Adenocarcinoma Incidence and Survival Trends in South Australia, 1990–2017 , 2022, Cancers.

[2]  J. Meyerhardt,et al.  Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Lew,et al.  Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia , 2021, PloS one.

[4]  W. King,et al.  Mortality due to cancer treatment delay: systematic review and meta-analysis , 2020, BMJ.

[5]  L. Taylor,et al.  Centre for Health Record Linkage , 2020 .

[6]  H. Cohen,et al.  Older adult participation in cancer clinical trials: A systematic review of barriers and interventions , 2020, CA: a cancer journal for clinicians.

[7]  A. Gavin,et al.  Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project) , 2020, Gut.

[8]  B. Ebert,et al.  The impact of the COVID-19 pandemic on cancer care , 2020, Nature Cancer.

[9]  J. Lew,et al.  Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia. , 2019, Public health.

[10]  A. Jemal,et al.  Global patterns and trends in colorectal cancer incidence in young adults , 2019, Gut.

[11]  D. Roder,et al.  Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival , 2019, BMJ Open.

[12]  P. Gibbs,et al.  Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence? , 2019, Internal medicine journal.

[13]  M. Jenkins,et al.  Trends in Colon and Rectal Cancer Incidence in Australia from 1982 to 2014: Analysis of Data on Over 375,000 Cases , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[14]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[15]  J. Emery,et al.  Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[16]  L. Veerman,et al.  Health services costs for cancer care in Australia: Estimates from the 45 and Up Study , 2018, PloS one.

[17]  J. Emery,et al.  Evaluation of the benefits, harms and cost‐effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia , 2018, International journal of cancer.

[18]  Jane M. Young,et al.  Patterns of follow up and survivorship care for people with colorectal cancer in new South Wales, Australia: a population-based survey , 2018, BMC Cancer.

[19]  D. Roder,et al.  Use of guideline‐recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia , 2018, Journal of evaluation in clinical practice.

[20]  J. Lew,et al.  Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study. , 2017, The Lancet. Public health.

[21]  Jason P. Fine,et al.  Statistical Primer for Cardiovascular Research Introduction to the Analysis of Survival Data in the Presence of Competing Risks , 2022 .

[22]  M. Millan,et al.  Treatment of colorectal cancer in the elderly. , 2015, World journal of gastrointestinal oncology.

[23]  P. Gibbs,et al.  Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia. , 2015, Journal of geriatric oncology.

[24]  I. Lansdorp-Vogelaar,et al.  Optimising the expansion of the National Bowel Cancer Screening Program , 2014, The Medical journal of Australia.

[25]  K. Beckmann,et al.  Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population-based data linkage. , 2014, Journal of evaluation in clinical practice.

[26]  Jane M. Young,et al.  Does patient age still affect receipt of adjuvant therapy for colorectal cancer in New South Wales, Australia? , 2014, Journal of geriatric oncology.

[27]  J. Warren,et al.  Patterns of colorectal cancer care in Europe, Australia, and New Zealand. , 2013, Journal of the National Cancer Institute. Monographs.

[28]  J. Fine,et al.  A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. , 2013, Journal of clinical epidemiology.

[29]  Bing Li,et al.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. , 2011, American journal of epidemiology.

[30]  M. Solomon,et al.  Management of colorectal cancer , 2019, BMJ.

[31]  S. Lujic,et al.  Health, ageing and private health insurance: baseline results from the 45 and Up Study cohort , 2009, Australia and New Zealand health policy.

[32]  V. Beral,et al.  Cohort Profile: The 45 and Up Study , 2007, International journal of epidemiology.

[33]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[34]  H. Quan,et al.  New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. , 2004, Journal of clinical epidemiology.

[35]  R. Steele,et al.  Management of colorectal cancer , 2002, Postgraduate medical journal.

[36]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[37]  M Lunn,et al.  Applying Cox regression to competing risks. , 1995, Biometrics.

[38]  C. McHorney,et al.  Evaluation of the MOS SF-36 physical functioning scale (PF-10): I. Unidimensionality and reproducibility of the Rasch item scale. , 1994, Journal of clinical epidemiology.

[39]  OUP accepted manuscript , 2022, International Journal Of Epidemiology.

[40]  G. Young.  Clinical practice guidelines for the prevention, early detection and management of colorectal cancer , 2018 .

[41]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[42]  A. Stewart,et al.  Measuring Functioning and Well-Being: The Medical Outcomes Study Approach , 1992 .

[43]  S. Lujic,et al.  Australia and New Zealand Health Policy Open Access Health, Ageing and Private Health Insurance: Baseline Results from the 45 and up Study Cohort , 2022 .